Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. Ruff CT, Patel SM, Giugliano RP, Morrow DA, et al. N Engl J Med 2025;392:361-371.

Read + Share

Amedeo Smart

Independent Medical Education

Ruff CT, Patel SM, Giugliano RP, Morrow DA, et al. Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation. N Engl J Med 2025;392:361-371.
PMID: 39842011